Related Experiment Video

Updated: Aug 9, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding

Matthias Bruehlmeier1, Elisa García Garayoa, Alain Blanc

  • 1Paul Scherrer Institute, Center for Radiopharmaceutical Science, CH-5232 PSI, Villigen, Switzerland. peter.blaeuenstein@psi.ch

Nuclear Medicine and Biology
|April 4, 2002
PubMed

Insights

Modifying neurotensin analogues with technetium-99m enhances their stability and tumor targeting. These optimized radiolabeled peptides show increased uptake in neuroendocrine tumors, improving imaging potential.

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Oncology

Background:

  • Neurotensin (NT) receptors are key targets for neuroendocrine tumor (NET) imaging and therapy.
  • Developing stable radiolabeled NT analogues is crucial for effective diagnostic and therapeutic applications.

Purpose of the Study:

  • To investigate the impact of structural modifications on the in vitro catabolism and in vivo biodistribution of five novel technetium-99m ([99mTc])-labeled neurotensin analogues.
  • To identify NT analogues with enhanced stability and tumor-targeting capabilities for NETs.

Main Methods:

  • Synthesis and characterization of five distinct [99mTc]-labeled neurotensin analogues with modifications including N-terminal substitution, reduced peptide bonds, N-methylation, and amino acid replacement (Ile12 to Tle).
  • In vitro assessment of peptide stability against catabolism.
  • In vivo biodistribution studies in nude mice bearing HT29 human colorectal adenocarcinoma xenografts.

Main Results:

  • Structural modifications, including N-terminal acylation, reduced bond 8-9, N-methylation, and Ile12 to Tle substitution, resulted in varying degrees of peptide stabilization.
  • More stable [99mTc]-neurotensin analogues demonstrated significantly higher tumor uptake in HT29 xenografts.
  • High tumor-to-blood ratios, reaching up to 70, were achieved with the most stable analogues, indicating improved targeting efficacy.

Conclusions:

  • Strategic modifications of the neurotensin peptide chain can significantly enhance stability and improve tumor targeting in vivo.
  • The developed [99mTc]-neurotensin analogues hold promise as effective radiotracers for imaging neuroendocrine tumors.
  • Further research into these stabilized analogues could lead to advancements in NET diagnostics and therapeutics.

More Related Videos

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis

Published on: January 7, 2019

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...